The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort
Open accessAbstract
While neurodegenerative diseases are characterized by steady degeneration over relatively long timelines, it is widely believed that the early stages are the most promising for therapeutic intervention, before irreversible neuronal loss occurs. Developing a therapeutic response requires a precise measure of disease progression. However, since the early stages are for the most part asymptomatic, obtaining accurate measures of disease progression is difficult. Longitudinal databases of hundreds of subjects observed during several years with tens of validated biomarkers are becoming available, allowing the use of computational methods. We propose a widely applicable statistical methodology for creating a disease progression score (DPS), using multiple biomarkers, for subjects with a neurodegenerative disease. The proposed methodology was evaluated for Alzheimer’s disease (AD) using the publicly available AD Neuroimaging Initiative (ADNI) database, yielding an Alzheimer’s DPS or ADPS score for each subject and each time-point in the database. In addition, a common description of biomarker changes was produced allowing for an ordering of the biomarkers. The Rey Auditory Verbal Learning Test delayed recall was found to be the earliest biomarker to become abnormal. The group of biomarkers comprising the volume of the hippocampus and the protein concentration amyloid beta and Tau were next in the timeline, and these were followed by three cognitive biomarkers. The proposed methodology thus has potential to stage individuals according to their state of disease progression relative to a population and to deduce common behaviors of biomarkers in the disease itself.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
The Alzheimer's Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.008 · Cited by 1,525
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336
Rizk-Jackson, A., Stoffers, D., Sheldon, S., Kuperman, J., Dale, A., Goldstein, J., Corey-Bloom, J., Poldrack, R. A., & Aron, A. R. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.273 · Cited by 107
Research works printed but not linked: 27
- Ashford, 1995, Temporal quantification of Alzheimer's disease severity: ‘Time Index’ model, Dementia, 6, 269
- Berg, 1988, Mild senile dementia of the alzheimer type: 2. Longitudinal assessment, Ann. Neurol., 23, 477, 10.1002/ana.410230509 · DOI · Paper page
- Brooks, 1993, The methodology of studying decline in Alzheimer's disease, J. Am. Geriatr. Soc., 41, 623, 10.1111/j.1532-5415.1993.tb06734.x · DOI
- Carroll, 1997, Generalized partially linear single-index models, J. Am. Stat. Assoc., 92, 477, 10.1080/01621459.1997.10474001 · DOI · Paper page
- Duara, 2011, Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates, Am. J. Geriatr. Psychiatry, 19, 951, 10.1097/JGP.0b013e3182107c69 · DOI
- Dubois, 2007, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria, Lancet Neurol., 6, 734, 10.1016/S1474-4422(07)70178-3 · DOI · Paper page
- Folstein, 1975, “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
- Hampel, 2008, Core candidate neurochemical and imaging biomarkers of Alzheimer's disease, Alzheimers Dement., 4, 38, 10.1016/j.jalz.2007.08.006 · DOI · Paper page
- Hardle, 1993, Optimal smoothing in single-index models, Ann. Stat., 21, 157, 10.1214/aos/1176349020 · doi:10.1214/aos/1176349020
- Hinrichs, 2011, Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population, NeuroImage, 55, 574, 10.1016/j.neuroimage.2010.10.081 · DOI · Paper page
- Jack, 2011, Evidence for ordering of alzheimer disease biomarkers, Arch. Neurol., 68, 1526, 10.1001/archneurol.2011.183 · DOI · Paper page
- Jicha, 2010, Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease, J. Alzheimers Dis., 19, 253, 10.3233/JAD-2010-1237 · DOI
- Levenberg, 1944, A method for the solution of certain non-linear problems in least squares, Q. Appl. Math., 2, 164, 10.1090/qam/10666 · DOI · Paper page
- Martin, 2002, vol. 3, 441
- Mitnitski, 1999, Modeling decline in Alzheimer's disease, Int. Psychogeriatr., 11, 211, 10.1017/S1041610299005761 · doi:10.1017/s1041610299005761
- Mosconi, 2007, Early detection of Alzheimer's disease using neuroimaging, Exp. Gerontol., 42, 129, 10.1016/j.exger.2006.05.016 · DOI · Paper page
- Mungas, 2000, Application of item response theory for development of a global functioning measure of dementia with linear measurement properties, Stat. Med., 19, 1631, 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1631::AID-SIM451>3.0.CO;2-P · DOI
- Qiu, 2008, Parallel transport in diffeomorphisms distinguishes time-dependent hippocampal surface atrophy in healthy aging and Alzheimer's disease, NeuroImage, 40, 68, 10.1016/j.neuroimage.2007.11.041 · DOI
- Richards, 1959, A flexible growth function for emperical use, J. Exp. Bot., 10, 290, 10.1093/jxb/10.2.290 · DOI · Paper page
- Sabuncu, 2011, The dynamics of cortical and hippocampal atrophy in Alzheimer disease, Arch. Neurol., 68, 1040, 10.1001/archneurol.2011.167 · DOI · Paper page
- Shaw, 2005, Molecular and cellular pathways of neurodegeneration in motor neurone disease, J. Neurol. Neurosurg. Psychiatry, 76, 1046, 10.1136/jnnp.2004.048652 · DOI · Paper page
- Stern, 1994, A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration, Am. J. Psychiatry, 151, 390, 10.1176/ajp.151.3.390 · DOI · Paper page
- Turner, 2009, Biomarkers in amyotrophic lateral sclerosis, Lancet Neurol., 8, 94, 10.1016/S1474-4422(08)70293-X · DOI · Paper page
- Turner, 2011, Towards a neuroimaging biomarker for amyotrophic lateral sclerosis, Lancet Neurol., 10, 400, 10.1016/S1474-4422(11)70049-7 · DOI · Paper page
- Walhovd, 2010, Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease, AJNR Am. J. Neuroradiol., 31, 347, 10.3174/ajnr.A1809 · DOI · Paper page
- Yang, 2011, Quantifying the pathophysiological timeline of Alzheimer's disease, J. Alzheimers Dis., 26, 745, 10.3233/JAD-2011-110551 · DOI
- Yang, 2011, Independent component analysis-based classification of Alzheimer's disease mri data, J. Alzheimers Dis., 24, 775, 10.3233/JAD-2011-101371 · DOI
Cited by
Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11934 · Cited by 1,202
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820
Alzheimer’s Disease: Past, Present, and Future
Bondi, M. W., Edmonds, E. C., & Salmon, D. P. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s135561771700100x · Cited by 649
Young, A. L., Marinescu, R. V., Oxtoby, N. P., Bocchetta, M., Yong, K., Firth, N. C., Cash, D. M., Thomas, D. L., Dick, K. M., Cardoso, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05892-0 · Cited by 596
Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Cedarbaum, J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.001 · Cited by 348
Metadata
- Authors
- Jedynak, B. M., Lang, A., Liu, B., Katz, E., Zhang, Y., Wyman, B. T., Raunig, D., Jedynak, C. P., Caffo, B., & Prince, J. L.
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 63
- Issue
- 3
- Pages
- 1478-1486
- ISSN
- 1053-8119 (ISSN-L)
- OpenAlex
- W2168818001
- Cited by
- 243
- References
- 6
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Pfizer Inc
- National Institute of Biomedical Imaging and Bioengineering (P41EB015909, R01EB012547)
- Ossoff Scholar Award
- National Institutes of Health (U01 AG024904)
- NIH (P30 AG010129, K01 AG030514)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort. https://app.cochat.ai/papers/10.1016/j.neuroimage.2012.07.059
- The paper
- Jedynak, B. M., Lang, A., Liu, B., Katz, E., Zhang, Y., Wyman, B. T., Raunig, D., Jedynak, C. P., Caffo, B., & Prince, J. L. (2012). A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort. NeuroImage. https://doi.org/10.1016/j.neuroimage.2012.07.059
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.